Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1867421 | 1.00 | HDAC4 (0.35) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL11138198 | 0.94 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL634692 | 0.94 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL153820 | 0.94 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| Ethyl Acetate SCHEMBL30319480 | 0.85 | ALDH1A1 (0.40) | CTSKALDH1A1RAB9A | |
| SCHEMBL29050640 | 0.77 | HDAC4 (0.33) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL15975034 | 0.77 | HDAC4 (0.37) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL9458910 | 0.77 | HDAC4 (0.37) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL1491166 | 0.76 | HDAC4 (0.34) | HDAC4HDAC2HDAC8HDAC6CTSK | |
| SCHEMBL6555849 | 0.76 | HDAC4 (0.34) | HDAC4HDAC2HDAC8HDAC6CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545856-B2 | Detergent compositions comprising secondary alkane sultanate, a second anionic surfactant, and alkyl hydroxysultaine cosurfactant | CONOPCO, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| EP-4682234-A1 | LAUNDRY ADDITIVE INCLUDING PERFUME, BACTERIAL SPORES AND ENZYMES | The Procter & Gamble Company (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20260015556-A1 | LAUNDRY ADDITIVE INCLUDING PERFUME, BACTERIAL SPORES AND ENZYMES | PROCTER & GAMBLE (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4448703-B1 | DETERGENT COMPOSITIONS | UNILEVER IP HOLDINGS B V (NL) | 2025-05-07 | — | — | EP | disclosed |
| EP-3990598-B1 | DETERGENT COMPOSITION | UNILEVER GLOBAL IP LTD (GB) | 2025-05-07 | — | — | EP | disclosed |
| CN-113993981-B | Detergent composition | 联合利华知识产权控股有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20250101341-A1 | DETERGENT COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2025-03-27 | — | — | US | disclosed |
| EP-3990602-B1 | DETERGENT COMPOSITION | UNILEVER GLOBAL IP LTD (GB) | 2025-02-26 | — | — | EP | disclosed |
| EP-4433568-B1 | DETERGENT COMPOSITIONS | UNILEVER IP HOLDINGS B V (NL) | 2025-02-26 | — | — | EP | disclosed |
| EP-4433567-B1 | DETERGENT COMPOSITIONS | UNILEVER IP HOLDINGS B V (NL) | 2025-02-12 | — | — | EP | disclosed |
| EP-3990603-A1 | DETERGENT COMPOSITION | UNILEVER GLOBAL IP LIMITED (GB) | 2022-05-04 | — | — | EP | disclosed |
| CN-114364776-A | Detergent composition | 联合利华知识产权控股有限公司 | 2022-04-15 | — | — | CN | disclosed |
| US-11268052-B2 | Container systems with water-soluble pouches comprising a PVOH resin blend | THE PROCTER & GAMBLE COMPANY (US) | 2022-03-08 | — | — | US | disclosed |
| WO-2022043138-A1 | SURFACTANT AND DETERGENT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-03-03 | — | — | WO | disclosed |
| WO-2022043042-A1 | DETERGENT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-03-03 | — | — | WO | disclosed |
| WO-2022042977-A1 | DETERGENT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-03-03 | — | — | WO | disclosed |
| WO-2022043045-A1 | DETERGENT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-03-03 | — | — | WO | disclosed |
| US-20220033736-A1 | DETERGENT COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2022-02-03 | — | — | US | disclosed |
| US-20220033732-A1 | DETERGENT COMPOSITION | CONOPCO, INC,, D/B/A UNILEVER (US) | 2022-02-03 | — | — | US | disclosed |
| CN-113993981-A | Detergent composition | 联合利华知识产权控股有限公司 | 2022-01-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545856-B2 | Detergent compositions comprising secondary alkane sultanate, a second anionic surfactant, and alkyl hydroxysultaine cosurfactant | SCD, STS, FFAR2 | HDAC4 3025/4885HDAC2 2360/4885HDAC8 2270/4885 |
| US-20260015556-A1 | LAUNDRY ADDITIVE INCLUDING PERFUME, BACTERIAL SPORES AND ENZYMES | LPL, PLG, PNLIP | HDAC4 1097/4885HDAC2 1018/4885HDAC8 1502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.